RPG Investment Advisory LLC Lowers Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

RPG Investment Advisory LLC lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.5% in the fourth quarter, Holdings Channel reports. The fund owned 25,631 shares of the exchange traded fund’s stock after selling 668 shares during the period. RPG Investment Advisory LLC’s holdings in SPDR S&P Biotech ETF were worth $2,308,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the company. Hartline Investment Corp lifted its stake in SPDR S&P Biotech ETF by 2.0% in the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock worth $544,000 after acquiring an additional 106 shares during the last quarter. Signature Estate & Investment Advisors LLC lifted its stake in SPDR S&P Biotech ETF by 5.7% in the third quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after acquiring an additional 125 shares during the last quarter. Graypoint LLC lifted its stake in SPDR S&P Biotech ETF by 5.6% in the third quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock worth $271,000 after acquiring an additional 146 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in SPDR S&P Biotech ETF by 0.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock worth $2,373,000 after purchasing an additional 148 shares in the last quarter. Finally, Key Financial Inc raised its holdings in SPDR S&P Biotech ETF by 24.6% during the third quarter. Key Financial Inc now owns 766 shares of the exchange traded fund’s stock worth $76,000 after purchasing an additional 151 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 1.1 %

XBI stock opened at $91.70 on Monday. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The company’s 50 day moving average is $91.36 and its two-hundred day moving average is $96.00. The stock has a market cap of $6.99 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.